These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 7721642)
1. Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Levin VA; Prados MR; Wara WM; Davis RL; Gutin PH; Phillips TL; Lamborn K; Wilson CB Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):75-83. PubMed ID: 7721642 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Levin VA; Maor MH; Thall PF; Yung WK; Bruner J; Sawaya R; Kyritsis AP; Leeds N; Woo S; Rodriguez L Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):357-64. PubMed ID: 7673023 [TBL] [Abstract][Full Text] [Related]
3. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233 [TBL] [Abstract][Full Text] [Related]
4. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1147-52. PubMed ID: 15001257 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Levin VA; Yung WK; Bruner J; Kyritsis A; Leeds N; Gleason MJ; Hess KR; Meyers CA; Ictech SA; Chang E; Maor MH Int J Radiat Oncol Biol Phys; 2002 May; 53(1):58-66. PubMed ID: 12007942 [TBL] [Abstract][Full Text] [Related]
6. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme. Groves MD; Maor MH; Meyers C; Kyritsis AP; Jaeckle KA; Yung WK; Sawaya RE; Hess K; Bruner JM; Peterson P; Levin VA Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):127-35. PubMed ID: 10477016 [TBL] [Abstract][Full Text] [Related]
7. Phase II trial of radiotherapy after hyperbaric oxygenation with multiagent chemotherapy (procarbazine, nimustine, and vincristine) for high-grade gliomas: long-term results. Ogawa K; Ishiuchi S; Inoue O; Yoshii Y; Saito A; Watanabe T; Iraha S; Toita T; Kakinohana Y; Ariga T; Kasuya G; Murayama S Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):732-8. PubMed ID: 21420247 [TBL] [Abstract][Full Text] [Related]
8. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Levin VA; Hess KR; Choucair A; Flynn PJ; Jaeckle KA; Kyritsis AP; Yung WK; Prados MD; Bruner JM; Ictech S; Gleason MJ; Kim HW Clin Cancer Res; 2003 Mar; 9(3):981-90. PubMed ID: 12631596 [TBL] [Abstract][Full Text] [Related]
9. Radiotherapy plus concurrent and adjuvant procarbazine, lomustine, and vincristine chemotherapy for patients with malignant glioma. Yang SH; Hong YK; Yoon SC; Kim BS; Lee YS; Lee TK; Lee KS; Jeun SS; Kim MC; Park CK Oncol Rep; 2007 Jun; 17(6):1359-64. PubMed ID: 17487391 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250 [TBL] [Abstract][Full Text] [Related]
11. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. Finlay JL; Boyett JM; Yates AJ; Wisoff JH; Milstein JM; Geyer JR; Bertolone SJ; McGuire P; Cherlow JM; Tefft M J Clin Oncol; 1995 Jan; 13(1):112-23. PubMed ID: 7799011 [TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma. Liau CT; Wei KC; Tseng CK; Jung SM Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144 [TBL] [Abstract][Full Text] [Related]
13. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD; Stelzer K; Brachman D; Suh JH; Schultz CJ; Bahary JP; Fisher BJ; Kim H; Murtha AD; Bell EH; Won M; Mehta MP; Curran WJ N Engl J Med; 2016 Apr; 374(14):1344-55. PubMed ID: 27050206 [TBL] [Abstract][Full Text] [Related]
14. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Prados MD; Scott C; Sandler H; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL; Greenberg HS; Curran WJ Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1109-15. PubMed ID: 10613302 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)]. Afra D; Sipos L; Vitanovics D Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study. Phillips TL; Levin VA; Ahn DK; Gutin PH; Davis RL; Wilson CB; Prados MD; Wara WM; Flam MS Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):709-14. PubMed ID: 1651306 [TBL] [Abstract][Full Text] [Related]
17. Concurrent modified PCV chemotherapy and radiotherapy in newly diagnosed grade IV astrocytoma. Murphy C; Pickles T; Knowling M; Thiesse B J Neurooncol; 2002 May; 57(3):215-20. PubMed ID: 12125984 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and feasibility of standard procarbazine, lomustine, and vincristine chemotherapy in anaplastic oligodendroglioma and oligoastrocytoma recurrent after radiotherapy. A Phase II study. Brandes AA; Tosoni A; Vastola F; Pasetto LM; Coria B; Danieli D; Iuzzolino P; Gardiman M; Talacchi A; Ermani M Cancer; 2004 Nov; 101(9):2079-85. PubMed ID: 15372474 [TBL] [Abstract][Full Text] [Related]
19. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy. Prados MD; Scott C; Curran WJ; Nelson DF; Leibel S; Kramer S J Clin Oncol; 1999 Nov; 17(11):3389-95. PubMed ID: 10550132 [TBL] [Abstract][Full Text] [Related]
20. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. Medical Research Council Brain Tumor Working Party J Clin Oncol; 2001 Jan; 19(2):509-18. PubMed ID: 11208845 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]